1-Ethyl-1H-pyrrole-2-carbaldehyde
Common Name: |
1-Ethyl-1H-pyrrole-2-carbaldehyde |
IUPAC Name: |
1-ethylpyrrole-2-carbaldehyde |
Molecular Formula: |
C8H10O2 |
SMILES: |
CCN1C=CC=C1C=O |
Inchi: |
1S/C7H9NO/c1-2-8-5-3-4-7(8)6-9/h3-6H,2H2,1H3 |
Inchi Key: |
DVLGEHCERRWDIX-UHFFFAOYSA-N |
Cas No: |
2167-14-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
138.16 |
Mass (g/mol) |
123.068 |
Molar Refractivity |
38.83 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
30.21 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
204.00 to 206.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.191 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
1.321 |
iLOGP |
2.14 |
XLOGP3 |
1.77 |
WLOGP |
2.10 |
MLOGP |
0.51 |
ESOL Log S |
-2.12 |
ESOL Solubility (mg/ml) |
1.06 |
ESOL Solubility (mol/l) |
0.008 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.02 |
Ali Solubility (mg/ml) |
1.31 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.69 |
Silicos-IT Solubility (mg/ml) |
0.28 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.89 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.634 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.956 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |